Viking Therapeutics (VKTX) Return on Equity [ROE] (2015 - 2026)
Viking Therapeutics (VKTX) reported Return on Equity [ROE] of -123.05% for Q2 2026, down 97.13 percentage points from -25.92% a year earlier and down 35.06 percentage points from the prior quarter.
Powered by 
Analysis
Viking Therapeutics (VKTX) Return on Equity [ROE] (2015 - 2026) Analysis & Trends
For FY2025, Viking Therapeutics posted Return on Equity [ROE] of -51.78%, down 27.21 percentage points from FY2024.
- Return on Equity [ROE] has a five-year change of -35.42 percentage points (FY2020 to FY2025).
- By year, Return on Equity [ROE] came in at -24.57% in FY2024 (+16.28 pp), -40.84% in FY2023 (-0.32 pp), -40.53% in FY2022 (-15.57 pp) and -24.96% in FY2021 (-8.59 pp).
- The Q2 2026 figure ranks as the lowest quarterly Return on Equity [ROE] since Q4 2017.
- Year over year, Return on Equity [ROE] has now declined in each of the last six quarters, with an average year-over-year change of -27.74 percentage points over the last eight quarters.
- The high point for year-over-year Return on Equity [ROE] in five years was Q1 2024 (a gain of 35.60 percentage points); the low point was Q2 2026 (a drop of 97.13 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at -87.99% (Q1 2026), -58.18% (Q4 2025) and -36.44% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | - |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 31.52% |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 4.97% |
| 10 | Viking Therapeutics | 2.85 Bn | 328.89 Mn | - | -123.05% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -123.05% |
| Mar 31, 2026 | -87.99% |
| Dec 31, 2025 | -58.18% |
| Sep 30, 2025 | -36.44% |
| Jun 30, 2025 | -25.92% |
| Mar 31, 2025 | -19.95% |
| Dec 31, 2024 | -16.85% |
| Sep 30, 2024 | -14.62% |
| Jun 30, 2024 | -13.44% |
| Mar 31, 2024 | -17.84% |
| Dec 31, 2023 | -28.14% |
| Sep 30, 2023 | -24.35% |
| Jun 30, 2023 | -31.05% |
| Mar 31, 2023 | -53.44% |
| Dec 31, 2022 | -47.44% |
| Sep 30, 2022 | -39.54% |
| Jun 30, 2022 | -34.41% |
| Mar 31, 2022 | -30.04% |
| Dec 31, 2021 | -26.83% |
| Sep 30, 2021 | -24.85% |
API Access
Viking Therapeutics Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=VKTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "VKTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=VKTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();